These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 3796341)
1. Dialysis encephalopathy in Kuala Lumpur. Abu Bakar Suleiman ; Rejab SM; Khoo HE Med J Malaysia; 1986 Mar; 41(1):12-8. PubMed ID: 3796341 [No Abstract] [Full Text] [Related]
2. Role of desferrioxamine in the treatment of dialysis encephalopathy. Ackrill P; Ralston AJ; Day JP Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985 [No Abstract] [Full Text] [Related]
4. [Successful treatment of progressive dialysis encephalopathy. Case report]. Weiland P; Köhler M; Glatzel E Z Urol Nephrol; 1985 Jul; 78(7):387-93. PubMed ID: 4050157 [TBL] [Abstract][Full Text] [Related]
5. [Current concepts of the role of aluminum in chronic kidney failure patients]. Gruev I; Belovezhdov N Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201 [No Abstract] [Full Text] [Related]
6. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease. Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691 [No Abstract] [Full Text] [Related]
7. [The natural history of dialysis encephalopathy (author's transl)]. Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340 [TBL] [Abstract][Full Text] [Related]
8. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)]. Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773 [TBL] [Abstract][Full Text] [Related]
9. Dialysis encephalopathy: precipitating factors and improvement in prognosis. Platts MM; Anastassiades E Clin Nephrol; 1981 May; 15(5):223-8. PubMed ID: 7249421 [TBL] [Abstract][Full Text] [Related]
10. Experiences with dialysis at the General Hospital, Kuala Lumpur. Sreenevasan G Br J Urol; 1970 Dec; 42(6):741. PubMed ID: 5497398 [No Abstract] [Full Text] [Related]
12. [Two forerunners of the encephalopathy of hemodialysed patients : osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)]. Vecchierini-Blineau MF; Thébaud HE; Brochard D; Coville P Nephrologie; 1980; 1(1):29-32. PubMed ID: 7301017 [TBL] [Abstract][Full Text] [Related]
14. Dialysis encephalopathy syndrome. Alfrey AC Annu Rev Med; 1978; 29():93-8. PubMed ID: 348053 [TBL] [Abstract][Full Text] [Related]
15. Encephalopathy in chronic renal failure appearing before the start of dialysis. Mehta RP Can Med Assoc J; 1979 May; 120(9):1112-4. PubMed ID: 445305 [No Abstract] [Full Text] [Related]
17. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure. Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766 [No Abstract] [Full Text] [Related]
18. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy. Milne FJ; Sharf B; Bell P; Meyers AM Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027 [TBL] [Abstract][Full Text] [Related]